TrialInvestigational new drugs2012

Progression-free survival and time to progression as surrogate markers of overall survival in patients with advanced gastric cancer: analysis of 36 randomized trials.

Kohei Shitara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.